Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
An uncommon cause of bifacial weakness and non-length-dependent demyelinating neuropathy.
Effects of Coenzyme Q10 on the ratio of TH1/TH2 in Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis in C57BL/6.
A competitive advantage by neonatally engrafted human glial progenitors yields mice whose brains are chimeric for human glia.
Comparison of serum vitamin D level in multiple sclerosis patients, their siblings, and healthy controls.
The Correlation between Aquaporin-4 Antibody and the Visual Function of Patients with Demyelinating Optic Neuritis at Onset.
Cortical Lesions in Multiple Sclerosis: Clinical Relevance for a Hidden Disease Burden.
High frequency of antiphospholipid antibodies in relapse of multiple sclerosis: a possible indicator of inflammatory-thrombotic processes.
Acute disseminated encephalomyelitis and other inflammatory demyelinating variants.
Rapid worsening of IgM anti-MAG demyelinating polyneuropathy during rituximab treatment.
Cerebral infarction following subcutaneous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy.
A rare case of oligoastrocytoma with atypical symptoms initially diagnosed as multiple sclerosis: A case report.
Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis.
Correction: Knowledge Retrieval from PubMed Abstracts and Electronic Medical Records with the Multiple Sclerosis Ontology.
Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis.
Examining the relationships between cortical maturation and white matter myelination throughout early childhood.
The carbocyanine dye DiD labels in vitro and in vivo neural stem cells of the subventricular zone as well as myelinated structures following in vivo injection in the lateral ventricle.
[Guillain-Barré syndrome with dysphagia after frontal sinusitis.]
Anti-MS4a4B treatment abrogates MS4a4B-mediated protection in T cells and ameliorates experimental autoimmune encephalomyelitis.
Elevated CNS inflammation in patients with preclinical Alzheimer's disease.
Searching for the neural basis of reserve against memory decline: intellectual enrichment linked to larger hippocampal volume in multiple sclerosis.
B cells and progressive multifocal leukoencephalopathy: search for the missing link.
Active Suppression Induced by Repetitive Self-Epitopes Protects against EAE Development.
Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis.
Using A Mixed Methods Approach to Develop A Discrete Choice Experiment In Multiple Sclerosis.
Cost-Effectiveness of Dimethyl Fumarate Treatment for Relapsing-Remitting Multiple Sclerosis From A Danish Perspective.
Pages
« first
‹ previous
…
672
673
674
675
676
677
678
679
680
…
next ›
last »